Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well, AS is certainly very pleased & Cytiva seemed to be bigging themselves up the other day too ! :-)
But what if we’ve got one? :-D
Titania..... Prof Rick Body from the Falcon arm of the CONDOR program has been quite vocal that very high sensitivity is not necessary so long as the test is being done every few days. So I don’t think CONDOR are necessarily looking for a Rolls Royce option. Cheers
It also seems to me that there are different segments in testing round Specificity, Sensitivity/ the level of Viral Load, time to results, ease of use, and cost. Sir Al did start discussing these in his video on Specificity and Sensitivity.
A cheap, fast test with high sensitivity at low viral loads but with higher false positives has real value. Does anyone get a sense if Condor gets this? Or are we running the risk of Condor looking for the Rolls Royce of testing?
Interesting Q&A CO, I also though this snippet from page 17 was worth a mention:
“We do request that anything that generally falls below a 95% sensitivity compared to a good swab sample or another good test be labeled with the negatives being presumed negative rather than actually negative.”
So... Over 80% useful, over 90% excellent, over 95% and the negatives can be confident and it’s a PCR killer as there’s no need for any confirmatory testing. Mass testing not mass screening.
An urgent read
Just out
1
17
32
Bond Digital Health
@bondhealthUK
·
5h
"COVID-19 antibody testing not yet a 'game changer'"
An interesting look at the slow progress of point of care antibody testing in the UK.
This is why we need rapid antigen tests with web connection and data.
https://twitter.com/bondhealthUK/status/1293524642016235520?s=20
Rapid antigen tests required
Indeed, world class you might say
Just avacta then, trail blazing
Link and quote...
https://orasure.gcs-web.com/news-releases/news-release-details/orasure-technologies-inc-announces-2020-second-quarter-financial
OraQuick Coronavirus Rapid Antigen Self-Test on track for EUA submission and subsequent launch in the fourth quarter. OraSure is developing a rapid antigen self-test, designed to produce a result for active COVID-19 infection within minutes, with no instrumentation needed to interpret the results and no need to transport samples to a lab for processing, enabling the detection of COVID-19 infection anytime, anywhere. The development of the test is supported by $710,310 of funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS). The test is currently in human clinical testing. Although originally intended for use with oral fluid, this test has been modified to employ an easily and comfortably self-collected lower nostril sample in order to achieve the best possible accuracy. The Company fully expects to meet or exceed applicable FDA performance requirements, with EUA filing and subsequent commercial launch in the fourth quarter, pending regulatory approvals. To date, there are no COVID-19 tests for active infection which provide a result at the point of collection with no need for a diagnostic instrument to interpret the result. Having said that, Awacta are just about to launch a saliva test so we’re thinking about not bothering as they’ll dominate and make gazillions.
Toaster, they’ve gone back to the drawing board, they’re not using saliva anymore. They’re now aiming for Q4 so they’ve fallen behind.
It’s not clear where they’re up to with it and what sample type etc. They’ve said they started collaborating at the end of July, so I’m guessing they’re a long way behind. Alternatively MIT are pretty much there and they’re now lined up with a manufacturer so very similar to Awacta and BBI. I’ve not managed to find anything else on it.
PL75 you say Orasure have fallen by the way side is that just because they have gone quiet? Or have they given up because avacta will blow them out of the water ;)
Voyager2, are 3M results imminent? Overdue?
piece from 27 July on same test.
https://tinyurl.com/y5yw7hb7
3M have a test that is a pregnancy style test and 10 mins but does require 'minimal training' to administer. they are talking in this piece about scaling up globally. A test with no need for training (i.e. Avacta's) is evidently infinitely more useful.
I think that list did come from Laurence Kotlikoff and Michael Mina NY Times piece. But I have also seen a video of a TeraGroup piece of kit - have others seen this? Yes the latter is a machine but the turnaround time is seconds and the marginal cost is very low - just a tube. Will check out Gabe Olin’s question which I must have missed.
Read from Gabe Olin’s question from bottom of p.16.
Nope - I know of no remaining viable competition in the saliva LFT space, and here’s an interesting find about the difficulty of making saliva tests (not sure if it’s been posted here already but things get lost down the page) as posted on twitter by teaboy yesterday:
https://www.fda.gov/media/140975/download
If ours does the biz as we all hope and expect, methinks the moat will be wide, and full of angry crocodiles. Not only that, but Klaus will be stood on the far bank with his arms folded and a disapproving look on his face.
When you say your starter list, do you mean Michael Mina's? Now that Orasure have fallen by the wayside, we're the only saliva LFD on the planet. Unless anyone has found one since?
There's none with a rapid portable (no lab intervention) self administered test....